A headshot photo of Erin Winstanley.

Erin Winstanley, PhD

Associate Professor

Contact Information


  • Department of Behavioral Medicine & Psychiatry
  • School of Pharmacy
  • Department of Neuroscience
  • Rockefeller Neuroscience Institute

Graduate Training

  • Ph.D., Health Policy & Management, The Johns Hopkins Bloomberg School of Public Health (2006)
  • M.A., Sociology, University of Illinois at Chicago


  • Johns Hopkins School of Medicine, Behavioral Pharmacology Research Unit

Research Interests

Dr. Winstanley received her doctoral degree from The Johns Hopkins Bloomberg School of Public Health, she has postdoctoral training in behavioral pharmacology, and she has over 20 years of experience as a behavioral health services researcher. She is the Multiple Principal investigator (MPI) of the Appalachian Node of the NIDA Clinical Trials Network (CTN) and a Site PI for  the Tailored Retention and Engagement for Equitable Treatment of OUD and Pain (TREETOP) clinical research center at the University of Pittsburgh (Pitt) which is part of the NIH IMPOWR network. Her current research is focused on reducing the morbidity and mortality associated with the overdose epidemic, as well as the use of technology to improve access and quality of behavioral health services. More specifically, she is investigating cognitive impairments and brain abnormalities that result from opioid-related overdose and problems initiating buprenorphine treatment among individuals using fentanyl.

Grants and Research

Current Grants:


NIDA Clinical Trials Network (CTN) – Appalachian Node (UG3 DA 049436)

Multiple Principal Investigators: Jane Liebschutz, MD (Univ. of Pittsburgh) & Erin L. Winstanley

Funder: NIDA

Description: The Appalachian Node of the NIDA CTN facilitates and collaborates on multisite clinical studies investigating how to improve outcomes for individuals that use drugs.


Buprenorphine Treatment Engagement and Induction Problems Among Individuals Using Fentanyl (CTN-135)

Multiple Principal Investigators: Erin L. Winstanley & Sarah Kawasaki (Penn State Health)

Funder: NIDA CTN

Description: CTN-135 is investigation geographic variations in fentanyl availability and problems that clinicians encounter when initiating patients using fentanyl onto buprenorphine.


The Impact of Neurocognitive Functioning, Methamphetamine Use and Overdose on Engagement and Retention in Buprenorphine Treatment

Multiple Principal Investigator: Erin L. Winstanley & James J. Mahoney III

Funder: WVU Center for Foundational Neuroscience Research and Education

Description: This study is investigating neurocognitive functioning among patients receiving inpatient treatment for a substance use disorder.


Tailored Retention and Engagement for Equitable Treatment of OUD and Pain (TREETOP)

Multiple Principal Investigator: Jessica Merlin & Kevin Kraemer (University of Pittsburgh); Site Principal Investigator: Erin L. Winstanley

Funder: NIDA

Description: TREETOP is part of the HEAL Initiative - Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Center (RM1 DA055311). WVU is participating in two clinical trials investigating how to improve engagement and retention in treatment for individuals with co-occurring chronic pain and opioid use disorder.


Facilitating Supervised Self-Management of Stimulant Medications Among Adolescents: Improving Adherence, Reducing Stigma, and Supporting Caregivers

Principal Investigator: Artin Perse (PillSmart); Site Principal Investigator: Erin L. Winstanley

Funder: NIDA Phase I SBIR

Description: This grant is investigating a novel device and application to improve adolescent adherence to stimulant medication prescribed for ADHD.


Mining Heterogeneous Network Built from Multiple Data Sources to Reduce Opioid Overdose Risks

Principal Investigator: Yanfang Ye, PhD

Funder: National Science Foundation (NSF) (1908215)

Recent Publications


Winstanley EL, Thacker EP, Choo LY, Lander LR, Berry JH, Togighi B. Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use. Drug and Alcohol Dependence Reports (2022), 5: 100091. [Available for FREE]  


Stover AN, Rockett IRH, Smith GS, LeMasters T, Scott VG, Kelly KM, Winstanley EL. Distinguishing clinical factors associated with unintentional overdose, suicidal ideation, and attempted suicide among opioid use disorder in-patients. Journal of Psychiatric Research (2022), doi: https://doi.org/10.1016/j.jpsychires.2022.06.039.


Winstanley EL. Through the looking glass: Crack pipes, crackpots and crazy ideas on how to reduce drug-related harms. J Stud Alcohol Drugs. 2022 Jul; 83(4):623-624. PMID: 35838442.


Davis SM, Stover AN, Linn H, Dower J, McCawley D, Winstanley EL, Feinberg J. Establishing peer recovery support services to address the central Appalachian opioid epidemic: The West Virginia peers enhancing education, recovery and survival (WV PEERS) pilot program. Journal of Appalachian Health 2021; 3(3): 36-50. [Available for FREE]


Wang K, DiChiacchio T, Fang W, Lander L, Feinberg J, Xie C, Winstanley EL, Piamjariyakul U. Longitudinal study of impact of medication for opioid use disorder on Hamilton Depression Rating Scale. Journal of Affective Disorders 2021 Oct 17:S0165-0327(21)01092-2. doi: 10.1016/j.jad.2021.10.018. PMID: 34670131.


Liu S, Nwabueze C, Pan Y, Walter SM, Su B, Xu C, Winstanley EL, Wang K. Polysubstance use, mood disorders, and chronic conditions with anxiety in opioid patients. Western Journal of Nursing Research 2021; 2021 Jul 23:1939459211031988. doi: 10.1177/01939459211031988. PMID: 34301163.


Winstanley EL, Mahoney JJ, Castillo F, Comer SD. Neurocognitive impairments and brain abnormalities resulting from opioid-related overdoses: a systematic review. Drug and Alcohol Dependence 2021 Sep 1; 226:108838. doi: 10.1016/j.drugalcdep.2021.108838. PMID: 34271512. [Available for FREE]


Wagner K, Zhong Y, Teshale E, White K, Winstanley EL, Hettema J, Thornton K, Fiuty P, Page K. Hepatitis c virus infection and polysubstance use among young adult people who inject drugs in a rural county of New Mexico. Drug and Alcohol Dependence 2021 Mar 1; 220:108527. doi: 10.1016/j.drugalcdep.2021.108527. PMID: 33465605. [Available for FREE]


Zhang Y, Castracane AR, Winstanley EL. Gabapentin dispensing patterns in Ohio. Substance Abuse 2021 Mar 9:1-10. doi: 10.1080/08897077.2021.1891602. PMID: 33689673.


Mahoney JJ, Winstanley EL, Lander LR, Berry JH, Marshalek PJ, Haut MW, Marton JL, Kimble W, Armistead MA, Wen S, Cai Y, Hodder SL. High prevalence of co-occurring substance use in opioid use disorder: The emerging addiction epidemic in the United States. Addictive Behaviors 2021 Mar; 114:106752. doi: 10.1016/j.addbeh.2020.106752. PMID: 33348147. [Available for FREE]


Rosa C, Marsch LA, Winstanley EL, Brunner M, Campbell ANC. Using digital technologies in clinical trials: current and future applications. Contemporary Clinical Trials 2021 Nov 17;100: 106219. doi: 10.1016/j.cct.2020.106219. PMID: 33212293. [Available for FREE]


Winstanley EL, Lander LR, Zheng W, Law K, Six-Workman A, Berry JH. Rapid transition of individual and group-based behavioral outpatient visits to telepsychiatry in response to COVID-19. Journal of Addiction Medicine 2020 Oct 23. doi: 10.1097/ADM.0000000000000748. PMID: 33105168.  


Winstanley EL. Campbell N. OD: naloxone and the politics of overdose. Boston, MA, USA: MIT Press; 2020. ISBN: 978026043663. Addiction 2020 https://doi.org/10.1111/add.15212.


Stover AN, Rockett IRH, Smith GS, LeMasters T, Scott VG, Kelly KM, Winstanley EL. Feasibility and Acceptability of safety screening among individuals receiving addiction treatment services. Journal of Substance Abuse Treatment 2020 Oct;117:108092. doi: 10.1016/j.jsat.2020.108092. PMID: 32811626.


Hines K, Garofoli G, Garofoli M, Elswick B, Winstanley EL. Impact of naloxone education for patients receiving buprenorphine-containing prescriptions at an independence community pharmacy. Journal of the American Pharmacists Association 2020 Nov-Dec; 60(6): e205-e214. doi: 10.1016/j.japh.2020.07.015. PMID: 32800678.


Winstanley EL, Mahoney JJ 3rd, Lander LR, Berry JH, Marshalek P, Zheng W, Haut MW. Something to despair: Gender differences in adverse childhood experiences among rural patients. Journal of Substance Abuse Treatment 2020 Sep;116:108056. doi: 10.1016/j.jsat.2020.108056. PMID: 32741501; PMCID: PMC7720246. [Available for FREE]


Winstanley EL. The bell tolls for thee & thine: Compassion fatigue & the overdose epidemic, International Journal of Drug Policy 2020 Nov; 85:102796. doi: 10.1016/j.drugpo.2020.102796. PMID: 32499119.


Winstanley EL, Baugh GM, Garofoli M, Muzyk AJ. Experiences and opinions of health professional students participating in an opioid use disorder educational event. The Mental Health Clinician 2020, 10 (2): 49-54.  doi: 10.9740/mhc.2020.03.049. PMID: 32257732. [Available for FREE]


Lander LR, Zheng W, Mahoney JJ, Berry JH, Marshalek P, Hustead JD, Winstanley EL. Long-term Treatment Retention in West Virginia’s Comprehensive Opioid Addiction Treatment Program. Journal of the Neurological Sciences 2020, 411: 411:116712. doi: 10.1016/j.jns.2020.116712. PMID: 32058182. [Available for FREE]


Winstanley EL, Stover A, Feinberg J. Concurrent alcohol and opioid use among harm reduction clients. Addictive Behaviors, 2020; 100:106027. doi: 10.1016/j.addbeh.2019.06.016. PMID: 31683186.  [Available for FREE]


Winstanley EL, Lander LR, Berry JH, Mahoney JJ, Zheng W, Herschler J, Marshalek P, Sayres S, Mason J, Haut MW. West Virginia’s model of buprenorphine expansion: Preliminary results. Journal of Substance Abuse Treatment 2020, 108:40-47. doi: 10.1016/j.jsat.2019.05.005. PMID: 31221524. [Available for FREE]


Winstanley EL, Stover A. The Impact of the Opioid Epidemic on Children & Adolescents. Clinical Therapeutics, 2019, 41(9): 1655-1662. doi: 10.1016/j.clinthera.2019.06.003. PMID: 31303278. [Available for FREE]


Stover AN, Winstanley EL, Feinberg J. The Impact of rural classification systems on a comparison of risky drug-related behaviors in Kentucky and Ohio Counties. Journal of Human Behavior in the Social Environment, 2019, 29:301-307. doi: 10.1080/10911359.2018.1516591. PMID: 31303278.  [Available for FREE]


Penm J, MacKinnon NJ, Mashni R, Lyons M, Hooker E, Winstanley E, Carlton-Ford S, Connelly C, Tolle E, Boone J, Koechlin K, Defiore-Hyrmer J. Emergency physicians’ perception of barriers and facilitators for adopting an opioid prescribing guideline in Ohio: A qualitative interview study. Journal of Emergency Medicine 2019, 56(1): 15-22. doi: 10.1016/j.jemermed.2018.09.005. PMID: 30342861.  [Available for FREE]


Winstanley EL, Stroup-Menge B, Snyder K. The Promise of Technology-Based Services for Addiction Treatment Clients Residing in Nonurban Areas. Journal of Studies on Alcohol & Drugs, 2018 May;79(3):503-504. doi: 10.15288/jsad.2018.79.503. PMID: 29885160; PMCID: PMC6005248. [Available for FREE]


Penm J, MacKinnon NJ, Mashni R, Lyons M, Hooker E, Winstanley EL, Carlton-Ford S, Connelly C, Tolle E, Boone J, Koechlin K, Defiore-Hyrmer J. Statewide cross-sectional survey of emergency departments’ adoption and implementation of the Ohio opioid prescribing guidelines and opioid prescribing practices. BMJ Open 2018 Jun 30;8(6):e020477. doi: 10.1136/bmjopen-2017-020477. PMID: 29961010.  [Available for FREE]


Winstanley EL, Zhang Y, Mashni R, Schnee S, Penm J, Boone J, McNamee C, MacKinnon NJ. Mandatory review of a prescription drug monitoring program and impact on opioid and benzodiazepine dispensing. Drug and Alcohol Dependence, 2018 Jul 1;188:169-174. doi: 10.1016/j.drugalcdep.2018.03.036. PMID: 29778769; PMCID: PMC6528173. [Available for FREE]


Winstanley EL, Burtchin M, Zhang Y, Campbell P, Pahl J, Beck S, Bohenek W. Inpatient Experiences with MyChart Bedside. Telemedicine Journal & E-Health, 2017 Aug;23(8):691-693. doi: 10.1089/tmj.2016.0132. PMID: 28328391; PMCID: PMC5749597. [Available for FREE]


Winstanley EL, Mashni R, Schnee S, Miller N, Mashni SM. The development and feasibility of a pharmacy-delivered opioid intervention in the emergency department. Journal of the American Pharmacists Association, 2017 Mar-Apr;57(2S):S87-S91. doi: 10.1016/j.japh.2017.01.021. PMID: 28292506; PMCID: PMC5527332. [Available for FREE]


Penm J, MacKinnon NJ, Boone JM, Ciaccia A, McNamee C, Winstanley EL. Strategies and policies to address the opioid epidemic: A case study of Ohio. Journal of the American Pharmacists Association 2017 Mar-Apr;57(2S):S148-S153. doi: 10.1016/j.japh.2017.01.001. PMID: 28189539; PMCID: PMC5497298. [Available for FREE]


Clark A, Breitenstein S, Martsolf DS, Winstanley EL. Assessing Fidelity of a Community-Based Opioid Overdose Prevention Program: Modification of the Fidelity Checklist. Journal of Nursing Scholarship 2016; 48 (4): 371-7. PMID: 27376347.


Winstanley EL, Clark A, Feinberg J, Wilder CM. Barriers to implementation of opioid overdose prevention programs in Ohio. Substance Abuse 2016; 37(1): 42-6. PMID: 26682929. [Available for FREE]


Winstanley EL. Tangled-up and blue: releasing the regulatory chokehold on take-home naloxone. Addiction. 2016 Apr;111(4):583-4. doi: 10.1111/add.13255. PMID: 26995167.


Butler MM, Ancona RM, Beauchamp GA, Yamin CK, Winstanley EL, Hart KW, Ruffner AH, Ryan SW, Ryan RJ, Lindsell CJ, Lyons MS. ED Prescription opioids as an initial exposure preceding addiction. Annals of Emergency Medicine 2016; 68(2): 202-8. PMID: 26875061. [Available for FREE]


Clark A, Winstanley EL, Martsolf DS, Rosen M. Implementation of an inpatient opioid overdose prevention program. Addictive Behaviors 2016; 53:141-5. PMID: 26517710.


Wilder CM, Miller SC, Tiffany E, Winhusen T, Winstanley EL, Stein MD. Risk factors for opioid overdose and awareness of overdose risk among veterans prescribed chronic opioids for addiction or pain. Journal of Addictive Diseases 2016; 35(1): 42-51. PMID: 26566771.  [Available for FREE]


Winstanley EL, Clark A, Wilder CM. Response to "Quality Assessment Errors and Study Misclassification Threaten Systematic Review Validity: Community Opioid Overdose Prevention and Naloxone Distribution Programs Review" Journal of Addiction Medicine 2015; 9(6):503-4. PMID: 26517326.


Rosa C, Campbell ANC, Miele G, Brunner M, Winstanley EL. Using E-Technologies in Clinical Trials. Contemporary Clinical Trials 2015; 45: 41-54. PMID: 26176884.  [Available for FREE]


Beauchamp GA, Winstanley EL, Ryan SA, Lyons MS. Moving Beyond Misuse and Diversion: The Urgent Need to Consider the Role of Iatrogenic Addiction in the Current Opioid Epidemic. American Journal of Public Health 2014 Sep 11: e1-e7. PMID: 25211712.  [Available for FREE]


Umbricht A, DeFulio A, Winstanley EL, Tompkins DA, Pierce J, Mintzer MZ, Strain EC, Bigelow GE. Topiramate for cocaine dependence during methadone maintenance treatment: A randomized controlled trial. Drug and Alcohol Dependence 2014; 140: 92-100. PMID: 24814607. [Available for FREE]


Wilder C, Brason FW 2nd, Clark AK, Galanter M, Walley AY, Winstanley EL. Development and Implementation of an Opioid Overdose Prevention Program within a Preexisting Substance Use Disorders Treatment Center. Journal of Addiction Medicine 2014; 8(3): 164-9. PMID: 24874760.


Clark A, Wilder CM, Winstanley EL. A Systematic Review of Community Opioid Overdose Prevention and Naloxone Distribution Programs. Journal of Addiction Medicine 2014; 8(3): 153-63. PMID: 24874759.


Winstanley EL, Brigham GS, Babcock D, Winhusen T. Improving treatment for opioid dependence: A perspective from the Ohio Valley Node of the NIDA Clinical Trials Network. Progress in Community Health Partnerships: Research, Education, and Action 2014; 8(1): 99-107. PMID: 24859107.  [Available for FREE]


Winstanley EL, Gay J, Roberts L, Moseley J, Hall O, Beeghly BC, Winhusen T, Somoza E. Prescription Drug Abuse as a Public Health Problem: A Case Report from Ohio. Public Health Nursing 2012; 29(6): 553-562. PMID: 23078426


Winstanley EL, Steinwachs DM, Stitzer ML, Fishman MJ. Adolescent Substance Abuse and Mental Health: Problem Co-occurrence and Access to Services. Journal of Child & Adolescent Substance Abuse 2012; 21:310-322. PMID: 24532964.  [Available for FREE]


McElroy SL, Winstanley E, Mori N, Martens B, McCoy J, Moeller D, Guerdjikova A, Keck PE. A Randomized, Placebo-Controlled Study of Zonisamide to Prevent Olanzapine-Associated Weight Gain. Journal of Clinical Psychopharmacology 2012; 32(2):165-72. PMID: 22367654.


Winhusen T, Winstanley EL, Somoza E, Brigham G. The potential impact of recruitment method on sample characteristics and treatment outcomes in a psychosocial trial for women with co-occurring substance use disorder and PTSD. Drug and Alcohol Dependence 2011; 120:225-8. PMID: 21752556.  [Available for FREE]


Guerdjikova AI, McElroy SL, Winstanley EL, Nelson EB, Mori N, Long W, Keck PE, Hudson JI. Duloxetine in the Treatment of Binge Eating Disorder with Depressive Disorders-A Placebo Controlled Trial. International Journal of Eating Disorders 2011; 45(2): 281-9. PMID: 21744377.


Winstanley EL, Bigelow GE, Silverman K, Johnson RE, Strain EC. A Randomized Controlled Trial of Fluoxetine in the Treatment of Cocaine Dependence Among Methadone-Maintained Patients. Journal of Substance Abuse Treatment 2011; 40(3): 255-64. PMID: 21266301. [Available for FREE]


McElroy SL, Winstanley EL, Martens B, Patel NC, Mori N, Moeller D, McCoy J, Keck PE. A Randomized, Placebo-Controlled Pilot Study of Adjunctive Ramelteon in Ambulatory Bipolar I Disorder with Clinically Significant Sleep Disturbance. International Clinical Psychopharmacology 2011; 26(1):48-53. PMID: 20861739.


McElroy SL, Guerdjikova AI, Winstanley EL, O’Melia AM, Mori N, McCoy J, Keck PE, Hudson JI. Acamprosate in the Treatment of Binge Eating Disorder: A Placebo Controlled Trial. International Journal of Eating Disorders 2011; 44(1): 81-90. PMID: 2108041.


Fishman MJ, Winstanley EL, Curran E, Garrett S, Subramaniam G. Treatment of Opioid Dependence in Adolescents and Young Adults with Extended Release Naltrexone: Preliminary Case Series and Feasibility. Addiction 2010; 105(9):1669-76. PMID: 20626723.

McElroy SL, Guerdjikova AI, Winstanley EL, O’Melia AM, Mori N, Keck PE, Hudson JI. Sodium Oxybate in the Treatment of Binge Eating Disorder: Open-Label, Prospective, Flexible-Dose Study in Outpatients. International Journal of Eating Disorders 2010; 44(3): 262-268. PMID: 20209489.


McElroy SL, Martens BE, Winstanley EL, Creech R, Malhotra S, Keck PE. Placebo-Controlled Study of Quetiapine Monotherapy in Ambulatory Bipolar Spectrum Disorder with Moderate-to-Severe Hypomania or Mild Mania. Journal of Affective Disorders 2009;124(1-2): 157-63.  PMID: 19963274.


Babor TF, Winstanley EL. The World of Drinking: National Alcohol Control Experiences in 18 Countries. Addiction 2008;103(5): 721-5. PMID:18412749.


Winstanley EL, Steinwachs DM, Ensminger ME, Latkin CA, Stitzer M L, Olsen Y. The Association of Neighborhood Disorganization and Social Capital with Adolescent Alcohol and Drug Use, Dependence, and Access to Treatment. Drug and Alcohol Dependence 2008; 92/1-3: 173-182. PMID:17913396.  [Available for FREE]


Winstanley EL, Gust SW, Strathdee SA. Drug abuse and HIV/AIDS: International Research Lessons and Imperatives. Drug and Alcohol Dependence 2006; 82,1: S1-S5. PMID: 16769437.


Book Chapters:


Winstanley EL, Newhouse A, Law KB. (2022) Chapter 44: The Impact on Families and Children. In Dunn K (Ed.), The Oxford Handbook of Opioids and Opioid Use Disorders, Oxford University Press. [forthcoming]


Morisano D, Winstanley EL, Morojele N, Babor TF. (2017) Chapter 5: Getting Started: Publication Issues for Graduate Students, Postdoctoral Fellows, and Other Aspiring Addiction Scientists. In: Babor TB, Stenius K, Savva S, O’Reilly J (Eds.), Publishing Addiction Science: A Guide for the Perplexed (3rd Edition), ISAJE/WHO. [Download for FREE]


Winstanley EL, Bolon SK, Fishman M. (2011) Chapter 37: Treatment Outcomes for Addictive Disorders. In: Miller NS & Gold MS (Eds.), Addictive Disorders in Medical Populations, Wiley, Inc. ISBN: 978-1-119-95630-3.


Morisano D, Babor TF, Winstanley EL.  (2008). Chapter 4, Getting Started: Publication Issues for Graduate Student, Postdoctoral Fellows, and Other Novice Addiction Scientists. In: In: Babor TB, Stenius K, Savva S, O’Reilly J (Eds.), Publishing Addiction Science: A Guide for the Perplexed (2nd Edition), ISAJE/WHO.


Babor TF, Morisano D, Stenius K, Winstanley EL, O’Reily, J. (2008). Chapter 2: How to Choose a Journal: Scientific and Practical Considerations. In: Babor TB, Stenius K, Savva S, O’Reilly J (Eds.), Publishing Addiction Science: A Guide for the Perplexed (2nd Edition), ISAJE/WHO.



Winstanley, EL and Newhouse A (September 2022) “Family Reunification and Engagement in Treatment Helps Parents Sustain Recovery,” Central East Addiction Technology Transfer Center (ATTC)’s The Dialogue eNewsletter.

Winstanley, EL. (May 2020) “Responding to the Silent Epidemic”, The Addiction Technology Transfer Center Network’s The Messenger.


Winstanley, EL. (March 2019) “Naloxone: Another Chance for Recovery”, The Addiction Technology Transfer Center (ATTC) Network’s The Messenger.


Winstanley, EL. (August 28, 2017) “The Opioid Epidemic is Finally a National Emergency – Eight Years too Late”, The Conversation (http://bit.ly/2whKeGn)


Winstanley, Erin L. (2012, May 11). “People Are Dying of Drug Overdoses, Despite Lifesaving Medications.” Huffington Post